Phathom Pharmaceuticals (PHAT) FCF Margin (2023 - 2026)
Phathom Pharmaceuticals (PHAT) reported FCF Margin of 26.84% for Q1 2026, up 27103.0% year-over-year from N/an in Q1 2025, and down 198.41% quarter-over-quarter from 8.99% in Q4 2025.
Phathom Pharmaceuticals (PHAT) FCF Margin (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 4 years of FCF Margin data on file, last reported at 26.84% in Q1 2026.
- FCF Margin for Q1 2026 came in at 26.84%, up 27103.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 47.69% (up 29782.0% YoY), and the FY2025 annual result was 95.37%, up 38770.0% from the prior year.
- FCF Margin eased to 26.84% in Q1 2026 per PHAT's latest filing, from 8.99% in the prior quarter.
- Over five years, FCF Margin peaked at 8.99% in Q4 2025 and troughed at 6254.55% in Q4 2023.
- A 4-year average of 1195.5% and a median of 255.9% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2025: FCF Margin jumped 604061 bps in 2024, then soared 20494 bps in 2025.
- A 4-year view of FCF Margin shows it stood at 6254.55% in 2023, then jumped by 97 bps to 213.93% in 2024, then surged by 96 bps to 8.99% in 2025, then plunged by 198 bps to 26.84% in 2026.
- Business Quant data shows PHAT's FCF Margin at 26.84% in Q1 2026, 8.99% in Q4 2025, and 28.38% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn | -26.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.84% |
| Dec 31, 2025 | -8.99% |
| Sep 30, 2025 | -28.38% |
| Jun 30, 2025 | -159.04% |
| Mar 31, 2025 | -297.86% |
| Dec 31, 2024 | -213.93% |
| Sep 30, 2024 | -389.51% |
| Jun 30, 2024 | -965.65% |
| Mar 31, 2024 | -3,610.20% |
| Dec 31, 2023 | -6,254.55% |